Camilo A. Campo

ORCID: 0000-0001-7506-4509
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • MRI in cancer diagnosis
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Advanced MRI Techniques and Applications
  • Radiation Dose and Imaging
  • Vascular Malformations Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Lanthanide and Transition Metal Complexes
  • Bariatric Surgery and Outcomes
  • Advanced X-ray and CT Imaging

University of Wisconsin–Madison
2016-2022

Highland Community College - Illinois
2022

University of California System
2021

University of California, San Francisco
2021

Harvard University
2021

Wisconsin Institutes for Discovery
2017

Virginia Commonwealth University
2016

University of California, San Diego
2016

The purpose of this study was to evaluate the reproducibility (interreviewer agreement) and repeatability (intrareviewer ROI sampling strategies measure chemical shift-encoded (CSE) MRI-based liver proton density fat fraction (PDFF) R2* (1 / T2*). A secondary standardize ROI-based PDFF measurements by providing a compromise between measurement time burden for image analysts.CSE data from two cohorts were retrospectively analyzed. Cohort included 53 patients referred abdominal MRI healthy...

10.2214/ajr.17.17812 article EN American Journal of Roentgenology 2017-07-14

Purpose Ferumoxytol (FE) has gained interest as an alternative to gadolinium‐based contrast agents (GBCAs). The purpose of this study was evaluate and optimize ferumoxytol dose T1 weighting, in comparison a conventional GBCA. Materials Methods Twelve healthy volunteers (six women / six men, mean age 44.3 years) were recruited for study. Scanning performed on clinical 3 Tesla (T) MRI system. Gadobenate dimeglumine (GD)‐enhanced MRA followed by FE‐enhanced 1 month later. Volunteers randomly...

10.1002/jmri.25513 article EN publisher-specific-oa Journal of Magnetic Resonance Imaging 2016-11-10
Coming Soon ...